Log in to save to my catalogue

Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second...

Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4802885

Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort

About this item

Full title

Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort

Publisher

England: BioMed Central

Journal title

Arthritis research & therapy, 2016-03, Vol.18 (1), p.71-71, Article 71

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

With regard to switching tumor necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA), conflicting results have been reported as to whether the effectiveness of a second TNFi depends on the reason for discontinuation of the first TNFi.
Patients with a clinical diagnosis of axSpA starting a second TNFi in the Swiss Clinical Quality...

Alternative Titles

Full title

Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4802885

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4802885

Other Identifiers

ISSN

1478-6362,1478-6354

E-ISSN

1478-6362

DOI

10.1186/s13075-016-0969-2

How to access this item